AHL
BSX icon

Abel Hall LLC’s Boston Scientific BSX Stock Holding History

Abel Hall LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,114
Closed -$202K – 838
2025
Q4 		$202K Buy
2,114
+7
+0.3% +$686 0.05% 541
2025
Q3 		$206K Sell
2,107
-1,404
-40% -$145K 0.08% 256
2025
Q2 		$377K Buy
3,511
+129
+4% +$13.1K 0.17% 121
2025
Q1 		$341K Buy
+3,382
New +$341K 0.21% 86

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Abel Hall LLC's BSX Position: Q1 2026 in Review

Abel Hall LLC sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,114 shares — an estimated $202K sold.

Abel Hall LLC first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $377K in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Abel Hall LLC reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 2,114 Boston Scientific shares in Q1 2026, an estimated $202K.
  • Abel Hall LLC first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Abel Hall LLC's Boston Scientific position peaked at $377K in Q2 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.